Meier F., Braun M., Ried J., Dabrock P., (2015): [Healthy or ill? Patients between technologies of the self and blurred identities] Dabrock P, Braun M,

Slides:



Advertisements
Similar presentations
PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Advertisements

School Social Work in Randolph County. Community School Family Students School Social Workers: Connecting Schools, Students, Families & Communities.
Victoria Veltri, JD, Advocate Jody Rowell, LCSW CT-DPH and CTAAP Teleconference Series Medical Necessity Denials: Strategies for Success.
EU Cross-Border Care Directive from the Primary Care perspective Results of a simulation Rita Baeten Gothenburg, 3 September 2012.
L1:Apply the concepts of health and wellness to identify health behaviours and factors influencing choice and change in health using an holistic approach.
1 The FNR Foresight Thinking for the Future Today – A Participative Process.
INTRODUCTION The use of and interest in shared decision making (SDM) and decision aids (DAs) in the clinical setting has increased in recent years. Stakeholder.
Documentation for Acute Care
CSR Project, 3 cr. Corporate Responsibility, C-module (15 cr.) or free-choise studies Introduction to Corporate responsibility, 1,5-3 cr. (depending on.
FORCE XRAY PROGRAM Evaluating Reports on Breast Cancer in the Media.
Critical Appraisal of Clinical Practice Guidelines
Alessandra Gorini (Presenter) Via Conservatorio, Milano, Italy The P-medicine project:
DELAWARE HEALTH AND SOCIAL SERVICES Division of Public Health Public Health and PCMH Karyl Rattay, MD, MS Director Delaware Division of Public Health.
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
Simple. Scientifically Informed Medical Practice and Learning Suzana Alves da Silva, MD, MSc, PhD, FNYAM 2014 TEACH Workshop THE SECTION ON Evidence Based.
LESSON 7.9: THE PLAN (SOAP) Module 7: Violence Obj. 7.9: Develop a plan to attain health goals for a patient that addresses strengths, needs, and risks.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
The “HELP” program Introducing case management approaches to HIV services in Lithuania Professor Malcolm Whitfield Sheffield Hallam University, UK.
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
Oviedo Convention and Its Protocols – Impact on Polish Law International Bioethics Conference Oviedo Convention in Central and Eastern European Countries.
THE FRENCH NATIONAL CANCER INSTITUTE (INCa) Focusing care on patients The patient Committee.
The New ACGME Competencies for Internal Medicine.
JPI “More Years, Better Lives: The Potential and Challenges of Demographic Change” 1 GPC-Meeting, Brussels, Joint Programming Initiative “More.
Citizens’ contributions to the public agenda on animal cloning: project manager Ida-Elisabeth Andersen Structure of the presentation: 1.What is the Danish.
The Areas of Interaction are…
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
For Pharmacy Tech Training. Goal 1 Assist the pharmacist in collecting, organizing and evaluating information for direct patient care, medication use.
Access to Personalised Medicine for PDAC patients STSM of the application of an EU-index for barriers Denis Horgan (EAPM) & Angela Brand (IPHG) on behalf.
Physiotherapy in Palliative Care
Socio-cultural and ethical aspects Anne G. Ekeland Berlin,
Overview of Chapter The issues of evidence-based medicine reflect the question of how to apply clinical research literature: Why do disease and injury.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Assessing Quality of Care AHRQ State Healthcare Quality Improvement Workshop January 17, 2008 Rhonda Jaster Prevention Specialist.
NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.
Division of Technology, Industry, and Economics Economics and Trade Branch SESSION 7 - How to do Integrated Assessment Stage D: Issuing policy recommendations.
TOWARDS RECOVERY CLINICS Patient Care. Community Fit. An Integrated Approach to Comprehensive Treatment.
Policy Development Unit 7. 2 Policy Development l Policy: Authoritative guidelines that direct human behavior toward specific goals l Politics: Use of.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 5: INFORMATION COUNSELLING AND THE ROLE OF CONSENT.
Understanding Genetic Testing
SINGING FROM THE SAME HYMN SHEET Address to SATS Study Day 29 June 2013 Dr Sue Armstrong.
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
Workshop 18 th May 2010, Brussels Applying the Value+ model on patient involvement in HTA processes.
Learning Outcomes Discuss current trends and issues in health care and nursing. Describe the essential elements of quality and safety in nursing and their.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Kim Adams, RN,BN Masters candidate Holly Etchegary, PhD TPMI Research Day October 8, 2015.
Medical Ethics  A set of guidelines concerned with questions of right & wrong, of duty & obligation, of moral responsibility.  Ethical dilemma is a.
The National Cancer Research Network is part of the National Institute for Health Research CANCER GENETIC TRIALS Leicestershire, Northamptonshire and Rutland.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Genomics in Public Health.
Survivorship Essentials for Practice Administrators Christina Bach, MBE, MSW, LCSW, OSW-C Carolyn Vachani, MSN, RN, AOCN.
OUR FOCUS FOR 2011 TO 2012 The CfWI produces quality intelligence to inform better workforce planning, that improves people’s lives.
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Department of Human Services Self-management Improving care Caroline Frankland Senior Project Officer Health Independence Programs Department of Human.
Formative Evaluation of Interventions Addressing Culturally Relevant Needs of Young Breast Cancer Survivors Adina Fleischmann, LSW, Sharsheret; Mary Ann.
Hereditary Cancer Predisposition: Updates in Genetic Testing
Week 5: Ethical, Legal & Social Issues in Applied Genomics
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
Vrunda Bhavsar Desai MD, Janice Crabtree MS, Jessica Illuzzi MD, MS
1.04 Patient Rights Legislation
Vesa Tanner European Commission Directorate-General Energy
Chapter 5: Genetics and genomics perspectives in nursing
Genetics and Breast Cancer Adelphi 2018 Educational Forum Sharona Cohen, MS, CGC Certified Genetic Counselor Northwell Health.
Tit Albreht | Brussels | 7 November 2017
The International Consortium for Personalised Medicine
Component 1: Introduction to Health Care and Public Health in the U.S.
1.04 Patient Rights Legislation
And now the Framework WP4.
CEng progression through the IOM3
Presentation transcript:

Meier F., Braun M., Ried J., Dabrock P., (2015): [Healthy or ill? Patients between technologies of the self and blurred identities] Dabrock P, Braun M, Ried J, Schmutzler R (2015): From Chance to Bet Choice? A Primer to Ethical and Societal Issues in Systems Medicine Stefan Huster [The Genetic Diagnosis as Impuls for Innovations and Regulation of the public Heath Care System] Stefan Huster [The Meaning of term ‚disease‘ for the Health Insurance Law] Stefan Huster, Anke Harney [Discussion of the Judgment of the Administrative Court Darmstadt, Judgment 5/13/2015, AZ.: 1 K 491/13.DA] Schmutzler R., Wasem J., Huster S., Dabrock P.: [Challenges and Chances of stratified Prevention], Dtsch Artzbl 2015; 112 (20), A Schmutzler R., Huster S.: [Legal Aspects of current Developments in Genetic Cancer Diagnosis] MedR (2015) 33, 248–251. Several Activities such as Interviews in the Media and Participation in Public Panel Discussions Timeline Kick-off Event Q4/2014Q1/2015Q2/2015Q3/2015Q4/2015Q1/2016Q2/2016Q3/2016Q4/2016Q1/2017Q2/2017Q3/2017 Scenario Workshop First Common Paper (see below) Publications and Activities Forthcoming Publications Contact Coordination: Friedhelm Meier (Research Assistant) Department of Systematic Theology (Ethics) FAU Erlangen-Nuremberg Kochstrasse 6 D Erlangen Mail: Midterm Meeting Fourth WorkshopFifth Workshop Final Meeting Second Common Paper Governance Recommendations Second Workshop Scenario Workshop Semi-Structured Interviews Model of Risk Communication Developing a Regulation Model Calculation of Budget Impacts Identified the relevant ethical and social issues of systems medicine Analysed and extended the ‘healthy ill’ model and its impact on the BRCA 1/2 case Explored, how systems medicine influences perceptions and concepts of health and illness Developed a mapping model of risk calculation and the appropriated preventive measures Findings and Prospects Psycho-social and Medical Sub-Project Legal Sub-Project Ethical Sub-Project Sub-Project Health Economics Developing a matrix for assessing normative challenges of systems medicine in general and BRCA 1/2 in particular Identified concepts and crucial factors of the remaining unexplained heritability of breast and ovarian cancer Generated evidence-based data for appropriate risk communication and perception Explored the influence of psychosocial factors and anxiety levels on decision making of BRCA 1/2 mutation carriers in preventive counselling The current German law is not applicable to tests concerning somatic genetic modifications Analysed legal positions dealing with the tumor tissue of deceased index patients Investigated legal aspects related to the reimbursement of genetic diagnostic by NGS and preventive mastectomy in the case of mutated BRCA1/2 Developed model structures according to screening and treatment strategies of BRCA 1/2 carriers Integrated results from systematic literature searches into the model Performing a budget impact analysis to calculate the economic consequences for the budget of the statutory health insurance Optimising risk communication to provide a structured psychosocial screening Analysing the impact of systems medicine for public health care and recommending amendments concerning the current legal situation Identifying the budgetary consequences in the public health care system Findings Prospects Findings Prospects Findings Developing common evaluation criteria Investigating implications for health care Discussing consequences for ‘health’ and ‘disease’ Performing empirical studies Developing benchmarks for a governance perspective Developing a structured concept for medical and psycho-oncological counselling Developing benchmarks for a governance perspective Developing a structured concept for medical and psycho-oncological counselling Established and maintaining a combined research and studies platform integrating stakeholders (breast cancer support groups, health insurances, health policy) Coordination Third Workshop Re-Configuration of Health and Disease. Ethical, Psycho-Social, Legal and Health Economic Challenges of Systems Medicine You can find further information on the QR code on